Literature DB >> 18239320

The effect of endothelial progenitor cells on the development of collateral formation in patients with coronary artery disease.

Yoshiki Matsuo1, Toshio Imanishi, Yasushi Hayashi, Yoshiaki Tomobuchi, Takashi Kubo, Takuzo Hano, Takashi Akasaka.   

Abstract

OBJECTIVE: Unlike arteriogenesis, little is known about the effects of vasculogenesis and its major effector cells, endothelial progenitor cells (EPCs) on collateral formation. In this study, we investigated whether or not the number and function of EPCs were associated with the development of collateral formation in patients with single-vessel coronary artery disease of chronic total occlusion (CTO). METHODS AND
RESULTS: The subjects were patients (n=35) undergoing coronary angiography (CAG) who had CTO in one major coronary artery. EPCs were isolated from peripheral blood samples and cultured. Their phenotypes were confirmed by uptake of acetylated LDL and binding of fluorescein isothiocyanate (FITC)-labeled Ulex europaeus agglutinin 1 (UEA-1) lectin. The numbers of colony-forming units (CFUs) and the senescent cells, determined by acidic beta-galactosidase staining, were counted. The angiogenic growth factors from the culture medium were also measured by ELISA. Patients with good collaterals (n=22, Rentrop class 2 and 3) exhibited an increased number of CFUs (p=0.023), reduced number of senescent cells (p=0.010), and higher concentration of b-FGF (0.036) in the culture medium, compared with subjects with poor collaterals (n=13, Rentrop class 0 and 1).
CONCLUSION: Our findings suggested that EPC-mediated angiogenesis might be associated with coronary collateral formation in humans.

Entities:  

Mesh:

Year:  2008        PMID: 18239320     DOI: 10.2169/internalmedicine.47.0284

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  7 in total

1.  Poor coronary collateral vessel development in patients with mild to moderate renal insufficiency.

Authors:  Shuang-lun Xie; Hai-yan Li; Bing-qing Deng; Nian-sang Luo; Deng-feng Geng; Jing-feng Wang; Ru-qiong Nie
Journal:  Clin Res Cardiol       Date:  2010-09-25       Impact factor: 5.460

2.  Transplantation of endothelial progenitor cells transfected with VEGF165 to restore erectile function in diabetic rats.

Authors:  Xin Gou; Wei-Yang He; Ming-Zhao Xiao; Ming Qiu; Ming Wang; Yuan-Zhong Deng; Chao-Dong Liu; Zao-Bing Tang; Jie Li; Yong Chen
Journal:  Asian J Androl       Date:  2010-11-29       Impact factor: 3.285

3.  Chemokine, vascular and therapeutic effects of combination Simvastatin and BMSC treatment of stroke.

Authors:  Xu Cui; Michael Chopp; Alex Zacharek; Cynthia Roberts; Mei Lu; Smita Savant-Bhonsale; Jieli Chen
Journal:  Neurobiol Dis       Date:  2009-07-08       Impact factor: 5.996

4.  Endothelial progenitor cells regenerate infracted myocardium with neovascularisation development.

Authors:  M T Abd El Aziz; E A Abd El Nabi; M Abd El Hamid; D Sabry; H M Atta; L A Rahed; A Shamaa; S Mahfouz; F M Taha; S Elrefaay; D M Gharib; Khaled A Elsetohy
Journal:  J Adv Res       Date:  2013-12-21       Impact factor: 10.479

5.  The relation between endothelial dependent flow mediated dilation of the brachial artery and coronary collateral development - a cross sectional study.

Authors:  Aydan Ongun Ozdemir; Sadi Gulec; Nihal Uslu; Cansin Tulunay Kaya; Cagdas Ozdol; Sibel Turhan; Yusuf Atmaca; Timucin Altin; Cetin Erol
Journal:  Cardiovasc Ultrasound       Date:  2009-06-15       Impact factor: 2.062

6.  Comparative Evaluation for Potential Differentiation of Endothelial Progenitor Cells and Mesenchymal Stem Cells into Endothelial-Like Cells.

Authors:  Dina Sabry; Olfat Noh; Mai Samir
Journal:  Int J Stem Cells       Date:  2016-05-30       Impact factor: 2.500

7.  Intermittent Hypoxia Induced Formation of "Endothelial Cell-Colony Forming Units (EC-CFUs)" Is Affected by ROS and Oxidative Stress.

Authors:  Katia Avezov; Dror Aizenbud; Lena Lavie
Journal:  Front Neurol       Date:  2018-06-14       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.